Rx Error Law Clears Congress—But Will It Work?

Ken Rankin
Published Online: Saturday, October 1, 2005

In a move designed to cut down on costly medication errors and other types of medical mistakes, Congress approved new legislation designed to encourage pharmacists, physicians, and other health care providers to voluntarily disclose errors without risking litigation or disciplinary action. Under the new Patient Safety Quality Improvement Act, health care providers who furnish information to a government database about errors that cause little or no patient harm will be shielded from penalties.

The law drew praise from the American Society of Health-System Pharmacists (ASHP), whose officials called the new system "an important step toward creating a fail-safe health care system." According to the ASHP officials, it is "essential that pharmacists and other health care providers can share information when an error happens, so that the events can be analyzed and prevented from occurring again."

Patient rights advocates at the People's Medical Society, however, raised concerns that the new law would have little effect on medication errors because the reporting procedure is strictly voluntary. Without mandatory error disclosure rules for pharmacists and other health professionals, there will be little reduction in the medical errors that claim thousands of lives annually, the group warned.

Mr. Rankin is a freelance medical writer.

Latest Articles
In case you got caught up in the Thanksgiving holiday rush, here are the top trending stories you may have missed in November:
Bryan Ziegler, PharmD, executive director of Kennedy Pharmacy Innovation Center, provides some resources for community pharmacists to use when implementing new collaborative services with primary care providers.
James Schiffer, RPh, associate at Allegaert Berger & Vogel LLC, discusses some tips for pharmacists who are facing a Drug Enforcement Administration audit.
Carlos Aquino, founder and president of PharmaDiversion LLC, talks about the importance of the Drug Enforcement Administration's (DEA) diversion website.
Latest Issues